Neuroone Med Technologies Co.
13F holders, Q2 2024 (June 30)18holders
4new positions
4sold out
$0.80avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Neuroone Med Technologies Co. in their 13F filings, unchanged from Q1 2024. 4 opened new positions and 4 sold out. The largest holders were Nantahala Capital Management, LLC ($761K), Vanguard Group Inc. ($736K) and Geode Capital Management, LLC ($207K).
- Company
- Neuroone Med Technologies Co.
- CUSIP
- 64130M209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $37K |
| Exits | 4 | $22K |
All 13F filers, Q1 2024 → Q2 2024: 154,713 shares bought and 266,173 shares sold, net −111,460 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Nantahala Capital Management, LLC | 0.08% | Reduce -20.7% | 950,962 | $761K |
| Vanguard Group Inc. | 0.00% | Add +0.0% | 919,528 | $736K |
| Geode Capital Management, LLC | 0.00% | Add +16.6% | 258,883 | $207K |
| Mayo Clinic | 4.80% | No change | 181,754 | $145K |
| Perkins Capital Management Inc. | 0.11% | No change | 150,000 | $120K |
| State Street Corp. | 0.00% | Add +15.3% | 59,499 | $48K |
| UBS Group AG | 0.00% | Add +52958.3% | 57,303 | $46K |
| MAI Capital Management | 0.00% | No change | 50,000 | $40K |
| Northern Trust Corp. | 0.00% | No change | 30,281 | $24K |
| Virtu Financial LLC | 0.00% | New | 19,149 | $15K |
| Raymond James & Associates | 0.00% | New | 17,400 | $14K |
| Princeton Global Asset Management LLC | 0.00% | No change | 16,833 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +62.9% | 11,403 | $9K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 10,400 | $8K |
| Osaic Holdings, Inc. | 0.00% | Add +259.7% | 1,259 | $1K |
| Nemes Rush Group LLC | 0.00% | No change | 433 | $346 |
| Bank of America Corp. | 0.00% | New | 216 | $173 |
| JPMorgan Chase & Co. | 0.00% | Add +3.6% | 57 | $46 |
"% of holder's portfolio" is NEUROONE MED TECHNOLOGIES CO's weight in each manager's 13F, not the share of Neuroone Med Technologies Co. the manager owns.